Floatz logo

Therapeutic Asset Ratings

153 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
ALLOPREGNAN-3.ALPHA.-OL-20-ONE
Parkinson Disease
Roberta BrintonP1CC (40)
Carbamazepine
Parkinson Disease
Cerevel Therapeutics, LLCP1CC (40)
FLORTAUCIPIR
Parkinson Disease
Mayo ClinicP1CC (40)
pdm608
Parkinson Disease
Calibr, a division of Scripps ResearchP1CC (40)
Selnoflast
Parkinson Disease
Hoffmann-La RocheP1CC (40)
TRN501
Parkinson Disease
SNLD, Ltd.P1CC (40)
Alloex
Parkinson Disease
The Foundation for Orthopaedics and Regenerative MedicineP1C (37)
ams2434
Parkinson Disease
University of ArkansasP1C (37)
Anpd001
Parkinson Disease
Aspen NeuroscienceP1C (37)
Autologous Midbrain Dopamine Neurons
Parkinson Disease
Penelope J. Hallett, Ph.D.P1C (37)
Bms-9894923
Parkinson Disease
Allyx TherapeuticsP1C (37)
DEXKETOPROFEN
Parkinson Disease
Hasan Kalyoncu UniversityP1C (37)
hl-400
Parkinson Disease
Highlightll Pharmaceutical (USA) LLCP1C (37)
Huc-Msc-Sev-001 Nasal Drops
Parkinson Disease
Xuanwu Hospital, BeijingP1C (37)
HUMAN FAECAL MATTER
Parkinson Disease
Chang Gung Memorial HospitalP1C (37)
Human Fgf-1
Parkinson Disease
Zhittya Genesis Medicine, Inc.P1C (37)
ips101a
Parkinson Disease
Innopeutics CorporationP1C (37)
Lbt-3627
Parkinson Disease
Longevity Biotech Australia Pty Ltd (subsidiary)P1C (37)
ly4006896
Parkinson Disease
Eli Lilly and CompanyP1C (37)
METAMIZOLE
Parkinson Disease
Hasan Kalyoncu UniversityP1C (37)
NEPENTHE
Parkinson Disease
Hasan Kalyoncu UniversityP1C (37)
nm-101
Parkinson Disease
Neuramedy Co. Ltd.P1C (37)
Stem-Pd
Parkinson Disease
Region SkaneP1C (37)
TENOFOVIR DISOPROXIL FUMARATE
Parkinson Disease
The Fourth Affiliated Hospital of Zhejiang University School of MedicineP1C (37)
Clozapine
Parkinson Disease
Ruijin HospitalEarly P1C (37)
Showing 101 to 125 of 153 assets
PreviousPage 5 of 7Next